Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Search content at Albert Einstein College of Medicine
Home
Faculty
Departments
Grants
Publications
Prizes
Clinical Considerations of Drug-Induced Hepatotoxicity
Melanie Hundt
, Mahmoud Galal Moawad Mohamed
, Lily Dara
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical Considerations of Drug-Induced Hepatotoxicity'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Considerations
100%
Drug-induced Liver Injury
100%
Drug-induced Hepatotoxicity
100%
Injury Pattern
33%
Acute Liver Failure
22%
Liver Injury
22%
Treatment Options
11%
High Mortality
11%
Clinical Presentation
11%
Most Common Cause
11%
Early Recognition
11%
Law
11%
Older Patients
11%
R-value
11%
Alanine Aminotransferase
11%
N-acetylcysteine
11%
Relative Height
11%
Drug Development
11%
Jaundice
11%
Alkaline Phosphatase
11%
Dietary Supplements
11%
Acetaminophen Toxicity
11%
Offending
11%
Bilirubin Level
11%
Drug Monitoring
11%
Drug Discontinuation
11%
Rechallenge
11%
Drug Withdrawal
11%
Herbal Supplements
11%
Characteristic Signature
11%
Hepatobiliary Disease
11%
Diagnosis of Exclusion
11%
Cholestatic Pattern
11%
Drug-induced Hepatitis
11%
De-challenge
11%
Medicine and Dentistry
Liver Toxicity
100%
Toxic Hepatitis
100%
Acute Liver Failure
20%
Liver Injury
20%
Bilirubin
10%
Alkaline Phosphatase
10%
Alanine Aminotransferase
10%
Jaundice
10%
Dietary Supplement
10%
Paracetamol
10%
Drug Withdrawal
10%
Hepatobiliary Disease
10%
Diagnosis of Exclusion
10%
N-Acetylcysteine
10%
Treatment Option
10%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatotoxicity
100%
Toxic Hepatitis
100%
Acute Liver Failure
20%
Liver Injury
20%
Bilirubin
10%
Alkaline Phosphatase
10%
Toxic Injury
10%
Drug Development
10%
Paracetamol
10%
Jaundice
10%
Alanine Aminotransferase
10%
Dietary Supplement
10%
Hepatobiliary Disease
10%
N-Acetylcysteine
10%